Evidence map›Paper›PMID 39262872›Full record

ArticleMediators of inflammation2022

Interference of Interleukin-1

Jun-Feng Cao, Xi Hu, Li Xiong, Mei Wu, Xingyu Yang, Chaochao Wang, Shengyan Chen, Hengxiang Xu, Huanyu Chen, Xuntai Ma and 2 more

Abstract read
In one paragraph

Article in Mediators of inflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Network analysis andFrontiers in pharmacology · 2025
    Article
  6. Article
  7. Interference of Interleukin-1Mediators of inflammation · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jun-Feng CaoClinical Medical College of Chengdu Medical College, Chengdu, China.ORCID https://orcid.org/0000-0002-4417-1771
Xi HuTaikang Tongji Wuhan Hospital, Wuhan, China.
Li XiongClinical Medical College of Chengdu Medical College, Chengdu, China.
Mei WuClinical Medical College of Chengdu Medical College, Chengdu, China.
Xingyu YangClinical Medical College of Chengdu Medical College, Chengdu, China.
Chaochao WangClinical Medical College of Chengdu Medical College, Chengdu, China.
Shengyan ChenClinical Medical College of Chengdu Medical College, Chengdu, China.
Hengxiang XuClinical Medical College of Chengdu Medical College, Chengdu, China.
Huanyu ChenBasic Medical College of Chengdu Medical College, Chengdu, China.
Xuntai MaClinical Medical College of Chengdu Medical College, Chengdu, China.ORCID https://orcid.org/0000-0002-4081-7520
Yongjie MiClinical Medical College of Chengdu Medical College, Chengdu, China.ORCID https://orcid.org/0000-0001-5555-1895
Xiao ZhangClinical Medical College of Chengdu Medical College, Chengdu, China.ORCID https://orcid.org/0000-0002-4485-9752

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Inflammation and apoptosis after spinal cord contusion (SCC) are important causes of irreversible spinal cord injury. Interleukin-1 Method: This study used bioinformatics to screen and analyze gene targets related to IL-1 Results: Bioinformatics analysis suggested a close relationship between IL-1 Conclusion: Inhibition of IL-1

Identifiers

PMID39262872
PMCPMC11390212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.